Virtus LifeSci Biotech Products ETF (BBP:NASDAQ) closed at $102.33 on October 26, 2026, up 0.26% on the day. The stock trades 7.0% below its 52-week high of $110.05 and 40.5% above its 52-week low of $72.81. Virtus LifeSci Biotech Products ETF is part of the Miscellaneous sector.
In 252 trading sessions since October 24, 2025, BBP closed higher on 135 days (54%). Its best day was August 19, 2026 (+6.21%) and its worst was October 16, 2026 (-4.17%). It never moved 10% or more in a single session.
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing. The fund is non-diversified.
Find more stocks like BBP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.